Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or Transplant-Deferred Newly Diagnosed Multiple Myeloma By Ogkologos - March 3, 2025 714 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CEPHEUS study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR ESMO Releases New Patient Guide in Hepatocellular Carcinoma June 30, 2020 Tovorafenib Approved for Some Children with Low-Grade Glioma May 28, 2024 Breaking: Longtime Broadcast Journalist Cokie Roberts Dies At 75 September 17, 2019 Mobile Care Center Brings Breast Cancer Treatment to Amish and Mennonite... December 18, 2019 Load more HOT NEWS Trastuzumab Deruxtecan Shows Promising Activity Among Patients with HER2-positive and Signal... Woman Donates 500 Care Packages To Breast Cancer Patients FDA Approves Pralsetinib for Non-Small Cell Lung Cancer with RET Gene... Time to meet our new chief scientist – Professor KJ Patel
